Crescita Therapeutics Inc. (TSE:CTX – Get Free Report)’s stock price was up 57% during mid-day trading on Monday . The company traded as high as C$0.74 and last traded at C$0.73. Approximately 639,938 shares traded hands during mid-day trading, an increase of 1,454% from the average daily volume of 41,177 shares. The stock had previously closed at C$0.47.
Crescita Therapeutics Stock Up 59.1%
The company has a debt-to-equity ratio of 2.98, a current ratio of 3.12 and a quick ratio of 2.29. The stock has a market capitalization of C$13.77 million, a price-to-earnings ratio of 37.00 and a beta of -0.39. The firm’s fifty day moving average is C$0.48 and its 200-day moving average is C$0.47.
About Crescita Therapeutics
Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The firm generates its revenue in the form of product sales and out-licensing revenue.
Recommended Stories
- Five stocks we like better than Crescita Therapeutics
- The “secret weapon” behind Microsoft, Meta, Amazon, and Google
- A personal warning from Martin Weiss (Please read)
- Elon Musk: This Could Turn $100 into $100,000
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- Iran isn’t the real war
Receive News & Ratings for Crescita Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescita Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
